Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities
Colby S. Shemesh, Joy Hsu, Iraj Hosseini, et al.
Molecular Therapy (2020) Vol. 29, Iss. 2, pp. 555-570
Open Access | Times Cited: 203

Showing 26-50 of 203 citing articles:

Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery
Geonhee Han, Dahye Noh, Hokyung Lee, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114973-114973
Open Access | Times Cited: 28
Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery
Qimanguli Saiding, Zhongyang Zhang, Shuying Chen, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115116-115116
Closed Access | Times Cited: 28
Dose fractionation of CAR-T cells. A systematic review of clinical outcomes
Matthew J. Frigault, Anand Rotte, Ayub Ansari, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 27
New immunotherapeutic approaches for cancer treatment
Amin Kamrani, Ramin Hosseinzadeh, Navid Shomali, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154632-154632
Closed Access | Times Cited: 27
Outer Membrane Vesicle‐Based Nanohybrids Target Tumor‐Associated Macrophages to Enhance Trained Immunity‐Related Vaccine‐Generated Antitumor Activity
Jie Liang, Fei Zhu, Keman Cheng, et al.
Advanced Materials (2023) Vol. 35, Iss. 46
Closed Access | Times Cited: 27
Immunotherapy and immunoevasion of colorectal cancer
Mohammad Al Zein, Mona Boukhdoud, Hadi Shammaa, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103669-103669
Closed Access | Times Cited: 26
Tumor-derived systems as novel biomedical tools—turning the enemy into an ally
Nimeet Desai, Pratik Katare, Vaishali Makwana, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 25
Advancing nanotechnology for neoantigen-based cancer theranostics
Jianhua Zou, Yu Zhang, Yuanbo Pan, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 7, pp. 3224-3252
Open Access | Times Cited: 14
Leveraging Senescent Cancer Cell Membrane to Potentiate Cancer Immunotherapy Through Biomimetic Nanovaccine
Chao Yang, Yinglu Chen, Jie Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 9
The landscape of neoantigens and its clinical applications: From immunobiology to cancer vaccines
Chiranjib Chakraborty, Anirban Majumder, Manojit Bhattacharya, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100177-100177
Open Access | Times Cited: 8
An OMV‐Based Nanovaccine as Antigen Presentation Signal Enhancer for Cancer Immunotherapy
Yichao Lu, Nana Ma, Keman Cheng, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Characterization of Tumor Antigens from Multi-omics Data: Computational Approaches and Resources
Yunzhe Wang, James Wengler, Yousheng Fang, et al.
Genomics Proteomics & Bioinformatics (2025)
Open Access | Times Cited: 1
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Therapeutic cancer vaccines revamping: technology advancements and pitfalls
Gabriele Antonarelli, Chiara Corti, Paolo Tarantino, et al.
Annals of Oncology (2021) Vol. 32, Iss. 12, pp. 1537-1551
Open Access | Times Cited: 52
Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors
Tong Ye, Feng Li, Guanghui Ma, et al.
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113927-113927
Closed Access | Times Cited: 50
Neoantigen Immunotherapeutic-Gel Combined with TIM-3 Blockade Effectively Restrains Orthotopic Hepatocellular Carcinoma Progression
Qingfu Zhao, Yunhao Wang, Binyu Zhao, et al.
Nano Letters (2022) Vol. 22, Iss. 5, pp. 2048-2058
Closed Access | Times Cited: 37
Cancer gene therapy goes viral: viral vector platforms come of age
Urban Bezeljak
Radiology and Oncology (2022) Vol. 56, Iss. 1, pp. 1-13
Open Access | Times Cited: 32
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
Zhe Jing, Shuqing Wang, Keyuan Xu, et al.
Advanced Science (2022) Vol. 9, Iss. 24
Open Access | Times Cited: 32
Ultrasound Responsive Nanovaccine Armed with Engineered Cancer Cell Membrane and RNA to Prevent Foreseeable Metastasis
Wenqi Sun, Panpan Ji, Tianhua Zhou, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 21
Application prospect of circular RNA-based neoantigen vaccine in tumor immunotherapy
Mohan Li, Yian Wang, Pan Wu, et al.
Cancer Letters (2023) Vol. 563, pp. 216190-216190
Closed Access | Times Cited: 20
Programming Injectable DNA Hydrogels Yields Tumor Microenvironment‐Activatable and Immune‐Instructive Depots for Augmented Chemo‐Immunotherapy
Yu Fan, Mengsi Zhan, Liang Junhao, et al.
Advanced Science (2023) Vol. 10, Iss. 29
Open Access | Times Cited: 19
Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ Vaccination
Yingmin Li, Yang Luo, Lamei Hou, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 22
Closed Access | Times Cited: 17
Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer
Laura Seclì, Guido Leoni, Valentino Ruzza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16591-16591
Open Access | Times Cited: 17
Enhancing immune responses of ESC-based TAA cancer vaccines with a novel OMV delivery system
Meiling Jin, Da Huo, Jingjing Sun, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Recent advances in mRNA‐based vaccine for cancer therapy; bench to bedside
Hadeel Ahmed Kenoosh, Harikumar Pallathadka, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 7

Scroll to top